Board of Directors
Peter Amon is the CEO of Hero, a brand focused consumer foods holding, founded 125 years ago in Lenzburg, Switzerland. Hero`s core product categories are Infant Nutrition and Fruit with a global footprint running operations in Europe, North America, MiddleEast/Africa, Turkey and China. Peter Amon was the President Continental Europe for ARAMARK, a global leader in professional services, providing catering and facilities management solutions around the world with more than 250.000 employees. Prior to joining ARAMARK, Peter Amon worked in various leadership roles for Unilever and Kraft Foods in Europe, the US and in Asia. He has a successful 20 year track record of managing global icon brands like Knorr, Lipton, Philadelphia or Lunchables as well as regional brands like Miracoli, Pfanni or Mondamin. Peter Amon received a MBA from the University of Würzburg, Germany. He is active in various boards of trustees and charitable organizations.
Dr. Gunnar Weikert
Gunnar has more than 10 years of experience in the pharmaceutical industry as a senior vice president and global head for life science deals at Bayer AG. While at Bayer, he oversaw venture investments in technology companies and collaborations representing some of the biggest deals between big-pharma and biotechnology in the late 1990′s. Gunnar holds an MD, a PhD in the field of metabolism from University of Düsseldorf, and an MBA.
Dr Andrew Kelly
Dr Andrew Kelly is one of Australia-New Zealand’s experienced biotech investment managers. He is a co-founder of BioPacificVentures, the $100 million venture capital fund specialising in health and wellness, including food & nutrition, health maintenance and the prevention and treatment of chronic disease. The fund has completed 11 investments (to 2008) across Australia and New Zealand. Prior to BioPacificVentures, Andrew managed seed funds in early stage technology development. However, the first 20 years of Andrew’s career were in science. This included Science General Manager at AgResearch New Zealand, Director of Rutherglen Research Institute in Victoria, Director of the Pastoral & Veterinary Institute in Victoria, and both MSc and PhD degrees in veterinary science.
Ross Dobinson has extensive corporate advisory and investment banking experience. Ross has also taken an entrepreneurial role in the commercialisation of technologies in a range of fields, including: agricultural science, pharmaceuticals, environmentally-friendly packaging, medical devices, drug delivery technology and nutriceuticals. Ross has experience in company formation, seed, mezzanine and IPO funding, specialising in the life sciences sector, where he has been a founding director, investor and executive of listed and unlisted companies.
Ross has a Bachelor of Business Degree from Queensland University of Technology.
Dr Ajai Puri
Ajai Puri holds a Ph.D. in Food Science from the University of Maryland and an MBA from the Crummer Business School, Rollins College. Ajai is a member of the Supervisory Board of Nutreco N.V., additionally he serves as an Independent Non-Executive Director on the Board of Britannia Industries Limited. As Executive Board Member and President -Research, Development and Product Integrity at Royal Numico (2003 -07), Ajai was responsible for developing and implementing a highly successful science-driven, consumer-led R & D strategy in the areas of infant nutrition and medical nutrition. Ajai had a long career at The Minute Maid Company / The Coca-Cola Company in the US. During his 22 year career with the Company, he held a variety of positions including that of Senior Vice President Technical (Science andTechnology). At Coca-Cola he was instrumental in developing the health and wellness beverage platform, central to juice beverages as carriers of nutrition.
David Sinclair PhD
David A. Sinclair, Ph.D. is a tenured professor at Harvard Medical School, co-Director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging, a Senior Scholar of the Ellison Medical Foundation, an honorary professor at Sydney University, and cofounder and co-chief editor of the scientific journal Aging. He has co-founded a variety of companies in the biotech and consumer health arena including Genocea and Sirtris Pharmaceuticals. He is currently a board member and investor in Segterra, a web-based healthcare company.